ask="1.000"
ask_size="1000"
average_daily_volume="1436730"
bid="0.940"
bid_size="2000"
book_value="0.606"
change="+0.005"
change_from_200_day_moving_average="-1.629"
change_from_50_day_moving_average="0.016"
change_from_52_week_high="-3.964"
change_From_52_week_low="0.466"
change_in_percent="+0.562%"
close="0.966"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="0.190"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.020"
high_52_weeks="4.930"
last_trade_date="1/26/2017"
last_trade_price="0.966"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.950"
low_52_weeks="0.500"
market_capitalization="6.90M"
moving_average_200_day="2.595"
moving_average_50_day="0.950"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.330"
open="1.000"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-62.773%"
percent_change_from_50_day_moving_average="+1.717%"
percent_change_from_52_week_high="-80.405%"
percent_change_from_52_week_low="+93.200%"
previous_close="0.961"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.084"
price_per_book="1.585"
price_per_sales="2.683"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.580"
stock_exchange="NCM"
symbol="OPXA"
volume="158887"
weeks_range_52="0.500 - 4.930"
